Certara, Inc.CERTEarnings & Financial Report
Certara is a global leader in biopharmaceutical software and consulting services, specializing in modeling, simulation, and regulatory science solutions. It serves pharmaceutical companies, biotech firms and healthcare stakeholders across all drug development stages, helping accelerate new therapy launches, lower R&D risks and cut overall development costs.
Revenue
$104.6M
Gross Profit
N/A
Operating Profit
$9.6M
Net Profit
$-2.0M
Gross Margin
N/A
Operating Margin
9.1%
Net Margin
-1.9%
YoY Growth
12.1%
EPS
$-0.01
Certara, Inc. Q2 FY2025 Financial Summary
Certara, Inc. reported revenue of $104.6M (up 12.1% YoY) for Q2 FY2025, with a net profit of $-2.0M (up 84.3% YoY) (-1.9% margin).
Key Financial Metrics
| Total Revenue | $104.6M |
|---|---|
| Net Profit | $-2.0M |
| Gross Margin | N/A |
| Operating Margin | 9.1% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
Certara, Inc. Q2 FY2025 revenue of $104.6M breaks down across 3 segments, led by Service Revenues Earned Over Time at $57.9M (55.3% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Service Revenues Earned Over Time | $57.9M | 55.3% |
| Transferred Over Time | $28.0M | 26.8% |
| Transferred At Point In Time | $18.7M | 17.9% |
Certara, Inc. Revenue by Segment — Quarterly Trend
Certara, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Service Revenues Earned Over Time and Transferred Over Time) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Service Revenues Earned Over Time | — | — | $60.8M | $57.9M |
| Transferred Over Time | — | — | $28.4M | $28.0M |
| Transferred At Point In Time | — | — | $15.4M | $18.7M |
Certara, Inc. Annual Revenue by Year
Certara, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $418.8M).
| Year | Annual Revenue |
|---|---|
| 2025 | $418.8M |
| 2024 | $385.1M |
| 2023 | $354.3M |
| 2022 | $335.6M |
Certara, Inc. Quarterly Revenue & Net Profit History
Certara, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $106.9M | +0.8% | $-8.8M | -8.2% |
| Q4 FY2025 | $103.6M | +3.3% | $-5.9M | -5.7% |
| Q3 FY2025 | $104.6M | +10.3% | $1.5M | 1.5% |
| Q2 FY2025 | $104.6M | +12.1% | $-2.0M | -1.9% |
| Q1 FY2025 | $106.0M | +9.7% | $4.7M | 4.5% |
| Q4 FY2024 | $100.4M | +14.0% | $6.6M | 6.6% |
| Q3 FY2024 | $94.8M | +10.8% | $-1.4M | -1.4% |
| Q2 FY2024 | $93.3M | +3.2% | $-12.6M | -13.5% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $93.3M | $94.8M | $100.4M | $106.0M | $104.6M | $104.6M | $103.6M | $106.9M |
| YoY Growth | 3.2% | 10.8% | 14.0% | 9.7% | 12.1% | 10.3% | 3.3% | 0.8% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.54B | $1.54B | $1.58B | $1.56B | $1.54B | $1.54B | $1.56B | $1.50B |
| Liabilities | $496.2M | $489.8M | $516.4M | $476.7M | $472.9M | $471.0M | $493.8M | $483.3M |
| Equity | $1.04B | $1.05B | $1.06B | $1.08B | $1.07B | $1.06B | $1.06B | $1.02B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $9.8M | $17.0M | $49.4M | $17.4M | $17.8M | $32.3M | $28.8M | $11.7M |